Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
| Sedergine* : | |
| Type | Medicine Non Marketed |
| Originator | B |
| Agent | Pacific Pharma |
| Distributor | Pacific Pharma |
| Laboratory | UPSA |
| Responsible Party | UPSA |
| Origin | France |
| Manufacturer | UPSA SAS |
| Origin | France |
| ATC | N02BA51 |
Sedergine* :
Sedergine* :
Sedergine* :
Sedergine* :
Sedergine* :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Acid base balance abnormal | Rare |
| Agranulocytosis | Rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
| Aplastic anemia | Rare |
| Asiderotic anemia | Rare |
| Asthma | Uncommon |
| Bleeding time prolonged | Not known |
| Bronchospasm | Rare |
| Cephalea | Rare |
| Cerebral haemorrhage | Very rare |
| Diarrhoea (Diarrhea) | Uncommon |
| Dyspepsia | Uncommon |
| Epistaxis (Nasal bleeding) | Not known |
| Erythema multiforme | Rare |
| Gastralgia | Common |
| Gastroduodenal haemorrhage | Rare |
| Gastroduodenal ulcer | Rare |
| Gastrointestinal perforation | Very rare |
| Gingival bleeding (Gingival hemorrhage) | Not known |
| Haematoma | Not known |
| Haemolysis | Not known |
| Haemolytic anemia | Not known |
| Hepatic function abnormal | Rare |
| Hypersensitivity reactions | Rare |
| Hypoacusis | Rare |
| Hypoglycaemia | Rare |
| Hypotension | Rare |
| Intraoperative hemorrhage (Operative hemorrhage) | Not known |
| Leucopenia (Leukopenia) | Rare |
| Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
| Microhemorrhage | Very Common |
| Nasal congestion | Rare |
| Nausea | Uncommon |
| Obnubilation | Rare |
| Pancytopenia | Rare |
| Rash erythematous | Rare |
| Reaction eczematous | Rare |
| Renal disorder | Rare |
| Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
| Reye's syndrome | Very rare |
| Rhinitis | Rare |
| Shock | Rare |
| Skin reaction | Rare |
| Stevens-Johnson syndrome | Rare |
| Thrombocytopenia (Thrombopenia) | Rare |
| Tinnitus | Rare |
| Transaminases increased | Very rare |
| Urogenital haemorrhage (Urogenital bleeding) | Not known |
| Urticaria | Rare |
| Vertigo | Rare |
| Visual disturbance | Rare |
| Vomiting | Uncommon |
Sedergine* :
| NB : Products With Same Indication |
Different Units By MoH Code
Sedergine* MoH 199 :
| Form | Tablet, Effervescent |
| Package Size | Box of 20 |
| Strength | 0.330g/0.200g |
| Storage Condition | <25°C None |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 3021/72 |
| Submission date | 01/01/1972 |
| Registration Year | 1972 |
| Archived Date | 2014 |
Price Comparison
| ● Country: | KSA | |
| ● Package Size: | 20 | |
| ● Public Price: | 4.8 SAR | ( 113,472.00 LBP ) |
| ● Pack size unit used: | 20 | |
| ● Cost/Unit: | 0,24 SAR | ( 0.00 LBP ) |
| ● Reference: | sfda | |
| ● Pricing Date: | 16/01/2021 | |
| ● Type: | Medicine Authorised |
| ● Country: | UAE | |
| ● Package Size: | 20's (10's Jar x 2) | |
| ● Public Price: | 8 AED | ( 193,288.00 LBP ) |
| ● Pack size unit used: | 20 | |
| ● Cost/Unit: | 0,4 AED | ( 0.00 LBP ) |
| ● Pricing Date: | 21/08/2019 | |
| ● Type: | Medicine Authorised |
| ● Country: | Abu Dhabi | |
| ● Package Size: | 20 (10x2) | |
| ● Public Price: | 8 AED | ( 193,288.00 LBP ) |
| ● Pack size unit used: | 20 | |
| ● Cost/Unit: | 0,4 AED | ( 0.00 LBP ) |
| ● Pricing Date: | 27/01/2021 | |
| ● Type: | Medicine Authorised |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
